Key points are not available for this paper at this time.
Design
Review
May support earlier insulin screening in at-risk patients; leaves open need for prospective validation before practice change.
Hyperinsulinaemia in the absence of impaired glucose tolerance and normal HbA1c may provide a much earlier indicator of detection for risk of metabolic disease and progression to metabolic syndrome and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Vaidya et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: